ALX vs MRK · P/E 63, rev $108.1M vs P/E 33, rev $16.61B
Alexanders Inc (ALX) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Alexanders Inc (ALX) is a reit - retail company listed on NYSE.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Latest reported ALX revenue for 2026-06-30 was $108.1M. Net income was $160.0M. ALX currently screens at market cap $1.30B and trailing P/E 63.5.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
ALX currently screens at market cap $1.30B and trailing P/E 63.5. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the ALX and MRK stock pages for the full models.
Not investment advice.